| ²é¿´: 319 | »Ø¸´: 1 | ||
gzbridge½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Çó·Ò뼸¾ä»°£¬±¾ÈË·Çҽҩרҵ£¬µ«ÒªÐ´¸öͨѶ¸å¡£¡£¡£¡£¡£¡£
|
|
µÚÒ»¾ä£ºThe ÈâµÄ£¨·¢Òô£¬¿´²»µ½£©proteoglycans in atherosclerosis. µÚ¶þ¾ä:Signalling pathways controlling the synthesis of proteoglycans(Biglycan) as a therapeutic target. µÚÈý¾ä£ºGPRC transactivation pathways are major contributors to proteogiycan synthesis. лл! |
» ²ÂÄãϲ»¶
085600µ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁÏר˶ µ÷¼Á
ÒѾÓÐ12È˻ظ´
0703»¯Ñ§µ÷¼Á325·Ö
ÒѾÓÐ7È˻ظ´
²ÄÁϹ¤³Ì310ר˶µ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
324Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
338Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúÒ½Ò©ÀàÎÄÕÂÕªÒªµÄ·Ò룬ººÒëÓ¢£¬·Ç³£¸Ðл£¡
ÒѾÓÐ1È˻ظ´
ÇëÎÊ£¬ÄÄλ´óÏÀÓнϺõÄҽҩרҵ·Òë´Êµä£¿ ÏÂÔØ¸ö
ÒѾÓÐ10È˻ظ´
Ò½Ò©»¯Ñ§·½Ãæ ×Ô¼ºÒѾ·ÒëÁËÒ»°ë£¬»¹Óм¸¾ä»°»¹µÃÇë½ÌÄú£¬×¨ÒµÐÔÓеãÇ¿¡£
ÒѾÓÐ3È˻ظ´
Ìì²´Ò»ÐÄ
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 50 (СѧÉú)
- ½ð±Ò: 193.7
- ºì»¨: 4
- Ìû×Ó: 218
- ÔÚÏß: 60.1Сʱ
- ³æºÅ: 1423415
- ×¢²á: 2011-09-30
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
gzbridge: ½ð±Ò+5, ¡ïÓаïÖú, ¸ÐлÄãµÄ»Ø¸´¡£ 2013-05-26 12:10:27
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
gzbridge: ½ð±Ò+5, ¡ïÓаïÖú, ¸ÐлÄãµÄ»Ø¸´¡£ 2013-05-26 12:10:27
|
µÚÒ»¾ä£º¶¯ÂöÖàÑùÓ²»¯ÖеÄÔʼµ°°×¾ÛÌÇ£¨¿ÉÄÜÊÇrude£¬´¿Êô²Â²â£© µÚ¶þ¾ä£º¿ØÖƵ°°×¾ÛÌÇ£¨Ë«ÌÇÁ´µ°°×¶àÌÇ£©µÄºÏ³ÉÐźÅͨ·×÷ΪÖÎÁÆ·½°¸ µÚÈý¾ä£ºGRPC·´Ê½¼¤»î;¾¶Êǵ°°×¾ÛÌǺϳɵÄÖ÷Ҫ;¾¶ |

2Â¥2013-05-24 09:29:28














»Ø¸´´ËÂ¥